Hledání článků
Filtry
The Wegener’s Granulomatosis Etanercept Trial (WGET) Resarch Group: Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med 2005;352: 351–361.
Esnault VLM, Ekhlas A, Delcroix C, et al. Diuretic and enhance sodium restriction results in improved antiproteinuric response to RAS blocking agents. J Am Soc Nephrol 2005;16:474–481.
MacIsasc, RJ, Tsalamandris C, Panagiotopoulos S, et al. Normoalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004;27:195–200.
Van Biesen W, Vanholder R, Veys N, Verbeke F, Lameire N. Efficacy of erythro poietin administration in the treatment of anemia immediately after renal transplantation. Transplantation 2005;79:367-368.
Schwarz A, Mengel M, Gwinner W, Radermacher J, Hiss M, Kreipe H, Haller H. Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 2005;67:341–348.
Tao Y, Kim J, Schrier RW, Edelstein CL. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol. 2005 Jan;16(1):46–51.
Humphreys BD, Soiffer RJ, Magee CC. Renal failure associated with cancer and its treatment: an update. J Am Soc Nephrol 2005;16:151–161.
Avesani CM, Draibe SA, Kamimura MA, Colugnati FAB, Cuppari L. Resting energy expenditure of chronic kidney disease patients. Influence of renal function and subclinical inflammation. Am J Kidney Dis 2004;44:1008–1016.
Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004;44(Suppl 2):S34–S38.
Gouva Ch, Nikolopoulos P, Ioannidis PA, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial. Kidney Int 2004;66:753–760.
Block A, Martin KJ, de Francisco ALM, Turner S, et al. Cinacalcet hydrochloride for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004;350:1516–1525.
Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005;16:180–188.
Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol 2005;16: 1035–1050.
Chan T-M, Tse K-C, Tang CS, et al. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 2005;16:1076–1084.
Wauters JP, Lameire N, Davison A, Ritz E. Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement. Nephrol Dial Transplant 2005;20:490–496.